2025 is almost undeniably among the top 5 warmest years on record for Earth. There is a 99.9% chance this year will rank that ...

A new study published in The New England Journal of Medicine showed that endoscopic radial artery harvesting results in fewer ...

Omeros’ Yartemlea gets US FDA approval to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy: Seattle Monday, December 29, 2025, 12:00 Hrs [IST] Omer ...

RESEARCHERS have identified p-tau217 as a powerful prognostic marker for cognitive impairment in people with idiopathic REM ...

The team has uncovered that the Irish Cervical Cancer Screening programme has prevented over 5500 cancers in Ireland, that ...

Retrospective cohort data suggest that controlling HDL, triglycerides, and HbA1c levels may lower psoriatic arthritis risk in psoriasis, highlighting cardiometabolic targets for prevention in routine ...

Infertility is a significant global health challenge impacting millions of families worldwide. Utilizing data from the Global ...

Bloomberg’s t Global Regulatory Brief reviews recent global regulatory developments, focusing on the EU, US, UK, and Singapore, as they introduce regulations on trading, market structures, and ...

The association between falls and visual function is shaped by living in homes with environmental hazards, according to a ...

Vaxcyte aims to revolutionize the pneumococcal vaccine market with VAX-31. Click here to read an analysis of PCVX stock now.

Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.

The U.S. FDA has approved narsoplimab (Yartemlea) as the first indicated therapy for hematopoietic stem cell ...